New drug combo aims to boost Life-Saving stem cell harvest for cancer patients
Disease control
Recruiting now
This study is testing whether adding a new drug called motixafortide to a standard treatment (G-CSF) helps collect more stem cells from patients with multiple myeloma. These stem cells are needed for a transplant procedure that can help control the cancer. The trial will compare …
Phase: PHASE3 • Sponsor: Guangzhou Gloria Biosciences Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC